Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/Thermo Fisher Scientific, Inc./ 8-K

Current Report · Items 2.02, 9.01 · 8-K

Thermo Fisher Scientific, Inc.

TMONYSEEQUITYCurrent

Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On October 21, 2026, the Registrant announced its financial results for the fiscal quarter ended September 26, 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.…

Filed Oct 21, 2026Accepted Oct 21, 2026, 6:03 AM EDTCIK 97745Accession 0000097745-26-000173
View company →Permanent SEC source ↗
Share

Press release in this filing

Thermo Fisher Scientific Reports Third Quarter 2026 Results →

Company context

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Current securities

TMONYSE · EQUITY · Current

Recent company filings

  1. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsOct 30, 2026
  2. 10-Q filingOct 30, 2026
  3. 4 filingSep 1, 2026
  4. 4 filingSep 1, 2026
  5. 4 filingSep 1, 2026

Registered securities in this filing

THERMO FISHER SCIENTIFIC INC. · 8-K · Filed 2026-10-21

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, $1.00 par value

Symbol
TMO
Exchange
NYSE
Classification
COMMON
Status
Current
Filing context

Context: c-2

Dimensions: us-gaap:StatementClassOfStockAxis

1.450% Notes due 2027

Symbol
TMO 27
Exchange
NYSE
Classification
DEBT
Filing context

Context: c-3

Dimensions: us-gaap:StatementClassOfStockAxis

1.750% Notes due 2027

Symbol
TMO 27B
Exchange
NYSE
Classification
DEBT
Filing context

Context: c-4

Dimensions: us-gaap:StatementClassOfStockAxis

Floating Rate Notes due 2027

Symbol
TMO 27D
Exchange
NYSE
Classification
DEBT
Filing context

Context: c-5

Dimensions: us-gaap:StatementClassOfStockAxis

0.500% Notes due 2028

Symbol
TMO 28A
Exchange
NYSE
Classification
DEBT
Filing context

Context: c-6

Dimensions: us-gaap:StatementClassOfStockAxis

1.375% Notes due 2028

Symbol
TMO 28
Exchange
NYSE
Classification
DEBT
Filing context

Context: c-7

Dimensions: us-gaap:StatementClassOfStockAxis

1.950% Notes due 2029

Symbol
TMO 29
Exchange
NYSE
Classification
DEBT
Filing context

Context: c-8

Dimensions: us-gaap:StatementClassOfStockAxis

0.875% Notes due 2031

Symbol
TMO 31
Exchange
NYSE
Classification
DEBT
Filing context

Context: c-9

Dimensions: us-gaap:StatementClassOfStockAxis

2.375% Notes due 2032

Symbol
TMO 32
Exchange
NYSE
Classification
DEBT
Filing context

Context: c-10

Dimensions: us-gaap:StatementClassOfStockAxis

3.650% Notes due 2034

Symbol
TMO 34
Exchange
NYSE
Classification
DEBT
Filing context

Context: c-11

Dimensions: us-gaap:StatementClassOfStockAxis

3.628% Notes due 2035

Symbol
TMO 35A
Exchange
NYSE
Classification
DEBT
Filing context

Context: c-12

Dimensions: us-gaap:StatementClassOfStockAxis

2.875% Notes due 2037

Symbol
TMO 37
Exchange
NYSE
Classification
DEBT
Filing context

Context: c-13

Dimensions: us-gaap:StatementClassOfStockAxis

1.500% Notes due 2039

Symbol
TMO 39
Exchange
NYSE
Classification
DEBT
Filing context

Context: c-14

Dimensions: us-gaap:StatementClassOfStockAxis

1.875% Notes due 2049

Symbol
TMO 49
Exchange
NYSE
Classification
DEBT
Filing context

Context: c-15

Dimensions: us-gaap:StatementClassOfStockAxis

Accession 000009774526000173 · 14 registered-security cover members

Read the exact SEC filing ↗

Disclosure sections

Items 2.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 2.02Item 2.02 - Results of Operations
Item 2.02 Results of Operations and Financial Condition. On October 21, 2026, the Registrant announced its financial results for the fiscal quarter ended September 26, 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Form 8-K and incorporated herein by reference. The information contained in this report and exhibits hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
Filed exhibits (1)
EX-99.1 (by filename) q32026earnings8kex99_1.htm

Exhibit 99.1 News Media Contact Information: Investor Contact Information: Sandy Pound Rafael Tejada Thermo Fisher Scientific Thermo Fisher Scientific Phone: 781-622-1223 Phone: 781-622-1356 E-mail: sandy.pound@thermofisher.com E-mail: rafael.tejada@thermofisher.com Thermo Fisher Scientific Reports Third Quarter 2026 Results Revenue Grew 9% Including 6% Organic Revenue Growth Grew GAAP Diluted EPS 9% and Adjusted EPS 15% Outstanding performance driven by proven growth strategy and PPI Business System WALTHAM, Mass. (October 21, 2026) - Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 26, 2026. Third Quarter Highlights • Third quarter revenue grew 9% to $12.14 billion • Third quarter GAAP diluted earnings per share (EPS) grew 9% to $4.64 • Third quarter adjusted EPS grew 15% to $6.68 “We are very pleased to deliver another excellent quarter, with outstanding financial performance on both the top and bottom line,” said Marc N. Casper, chairman and chief executive officer…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.